Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company (GCAN) Return on Sales (2017 - 2022)

Greater Cannabis Company's Return on Sales history spans 6 years, with the latest figure at 50.3% for Q1 2022.

  • For Q1 2022, Return on Sales fell 5333.0% year-over-year to 50.3%; the TTM value through Mar 2022 reached 50.3%, down 5333.0%, while the annual FY2021 figure was 47.68%, 2788.0% down from the prior year.
  • Return on Sales reached 50.3% in Q1 2022 per GCAN's latest filing, down from 47.68% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 22.95% in Q2 2020 to a low of 382.28% in Q1 2020.
  • Average Return on Sales over 5 years is 57.84%, with a median of 25.74% recorded in 2020.
  • The largest YoY upside for Return on Sales was 45165bps in 2018 against a maximum downside of -115762bps in 2018.
  • A 5-year view of Return on Sales shows it stood at 8.7% in 2018, then crashed by -2699bps to 243.56% in 2019, then surged by 92bps to 19.8% in 2020, then tumbled by -141bps to 47.68% in 2021, then dropped by -5bps to 50.3% in 2022.
  • Per Business Quant, the three most recent readings for GCAN's Return on Sales are 50.3% (Q1 2022), 47.68% (Q4 2021), and 62.45% (Q3 2021).